Genetic analysis indicates ovarian cancer may originate in fallopian tubesOctober 24, 2017Gynecologic Cancer
FDA approves biosimilar to bevacizumabSeptember 14, 2017GastroenterologyLung CancerGynecologic CancerCNS/Brain CancerRenal Cell CarcinomaNeuro-oncologyGastrointestinal Cancer
Is pain or dependency driving elevated opioid use among long-term cancer survivors?September 6, 2017GastroenterologyPatient & Survivor CareLung CancerGenitourinary CancerGynecologic CancerGastrointestinal Cancer
PORTEC-3: Possible benefit with combined CT/RT in high-risk endometrial cancerJune 15, 2017Gynecologic Cancer
VIDEO: Survival improves when cancer patients self-report symptomsJune 5, 2017Breast CancerGenitourinary CancerGynecologic CancerLung CancerPatient & Survivor Care
VIDEO: Routine genomic testing identifies actionable alterations in 52% of tumorsJune 5, 2017Gynecologic CancerHead & Neck/Thyroid CancersBreast CancerSarcoma & GISTCNS/Brain CancerGastroenterologyGastrointestinal Cancer
Immune-agonist combo has activity against several tumor typesJune 5, 2017Immuno-oncologyImmunotherapyBreast CancerMelanomaRenal Cell CarcinomaGynecologic CancerGenitourinary Cancer
As government-funded cancer research sags, scientists fear U.S. is ‘losing its edge’June 2, 2017Practice ManagementGynecologic Cancer
FDA okays pembrolizumab for certain solid tumors with common biomarkerMay 23, 2017GastroenterologyGynecologic CancerGastrointestinal Cancer
Pembrolizumab shows some activity against advanced endometrial cancerMay 18, 2017Gynecologic CancerImmuno-oncology
